When did IMMUNOCORE HOLDINGS PLC-ADR (IMCR) report earnings last quarter?
IMMUNOCORE HOLDINGS PLC-ADR (IMCR) last reported earnings on 2/25/2026.
NASDAQ:IMCR • US45258D1054
Past quarterly earnings results for IMMUNOCORE HOLDINGS PLC-ADR (IMCR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.60 | -0.25 | -141.86% | -27.66% | 104.478M | 109.46M | -4.55% | 24.30% |
| Q3 2025 | 0.00 | -0.27 | 100.00% | -100.00% | 103.693M | 102.19M | 1.47% | 29.22% |
| Q2 2025 | -0.20 | -0.20 | 0.30% | 13.04% | 97.964M | 96.667M | 1.34% | 30.02% |
| Q1 2025 | 0.10 | -0.40 | 125.17% | 120.41% | 93.881M | 89.846M | 4.49% | 33.16% |
| Q4 2024 | -0.47 | -0.26 | -79.43% | -17.50% | 84.052M | 87.627M | -4.08% | 19.80% |
| Q3 2024 | 0.17 | -0.36 | 147.46% | 235.84% | 80.248M | 82.179M | -2.35% | 23.17% |
| Q2 2024 | -0.23 | -0.49 | 52.62% | 36.64% | 75.347M | 76.071M | -0.95% | 26.02% |
| Q1 2024 | -0.49 | -0.37 | -32.79% | -15.22% | 70.502M | 72.811M | -3.17% | 58.29% |
| Q4 2023 | -0.40 | -0.28 | -42.33% | 36.87% | 70.162M | 69.061M | 1.59% | 45.99% |
| Q3 2023 | 0.05 | -0.36 | 114.16% | -64.10% | 65.153M | 63.514M | 2.58% | 58.14% |
| Q2 2023 | -0.36 | -0.42 | 13.29% | -106.45% | 59.789M | 60.544M | -1.25% | 86.84% |
| Q1 2023 | -0.43 | -0.40 | -5.61% | 14.23% | 44.541M | 52.671M | -15.44% | 98.22% |
| Q4 2022 | -0.63 | 0.00 | -2,070,618.95% | 48.33% | 48.06M | 53.418M | -10.03% | 629.29% |
| Q3 2022 | 0.14 | -0.33 | 142.72% | 115.16% | 41.2M | 34.282M | 20.18% | 595.95% |
| Q2 2022 | -0.18 | -0.84 | 78.95% | 83.09% | 32M | 19.743M | 62.08% | 458.46% |
| Q1 2022 | -0.50 | -1.09 | 54.42% | 45.87% | 22.47M | 8.321M | 170.04% | 171.70% |
| Q4 2021 | -1.23 | -1.13 | -8.25% | -49.02% | 6.59M | 7.833M | -15.87% | -11.19% |
| Q3 2021 | -0.93 | -0.88 | -6.00% | - | 5.92M | 7.561M | -21.70% | -10.98% |
| Q2 2021 | -1.04 | -0.98 | -5.69% | - | 5.73M | 7.978M | -28.18% | -64.28% |
| Q1 2021 | -0.92 | -0.83 | -10.26% | - | 8.27M | 10.242M | -19.25% | - |
| Q4 2020 | -0.82 | -1.08 | 23.93% | - | 7.42M | 9.874M | -24.85% | - |
| Q3 2020 | - | - | 6.65M | - | - | |||
| Q2 2020 | - | - | 16.042M | - | - |
Notes
IMMUNOCORE HOLDINGS PLC-ADR (IMCR) last reported earnings on 2/25/2026.
IMMUNOCORE HOLDINGS PLC-ADR (IMCR) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, IMMUNOCORE HOLDINGS PLC-ADR (IMCR) has beaten EPS estimates in 3 out of 4 releases.